DCGI Urged To Withdraw Approval For Bharat Biotech’s Covaxin
New Delhi: The All India Drug Action Network (AIDAN) has urged the Drugs Controller General of India (DCGI) to reconsider the recommendations of the SEC in granting the REU approval to Covaxin.
AIDAN has said it is shocked to learn about…